Skylinedx

Provider of gene expression profiling tests for personalized medicine

placeRotterdam, South Holland, Netherlands calendar_todayFounded 2005 groups61 employees language skylinedx.com

Registered entities

Social engagement

Social engagement: 6.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Novalis LifeSciences; 1 has since exited.

Investor typeCountShare
Venture capital457%
Private equity114%
Other / undisclosed229%

Recent activity

22 Jun 2026
Event
16th European Post-Chicago Melanoma/Skin Cancer Meeting
15 Jun 2026
Event
33rd Annual Meeting of the Working Group for Dermatological Histology (ADH)
3 Jun 2026
Event
European Society for Paediatric Infectious Diseases - ESPID Infectious Diseases – ESPID Annual Meeting
Coming soon